article thumbnail

Chelation Therapy Does Not Improve Outcomes after Heart Attack

DAIC

The TACT2 study was designed to replicate the results of a previous trial, TACT , which reported in 2012 that chelation reduced subsequent cardiovascular events after a heart attack. and Canadian patients with diabetes and a history of heart attack,” said Gervasio A. and Canada.

article thumbnail

New 'Atherosclerosis Atlas' Sheds Light on Heart Attacks, Strokes

DAIC

MILLER, PHD, LED THE DEVELOPMENT OF A NEW "ATHEROSCLEROSIS ATLAS" THAT DETAILS, AT THE LEVEL OF INDIVIDUAL CELLS, CRITICAL PROCESSES RESPONSIBLE FOR FORMING THE HARMFUL PLAQUE BUILDUP THAT CAUSES HEART ATTACKS, STROKES AND CORONARY ARTERY DISEASE. When they break loose, they can be deadly, triggering strokes and heart attacks.

article thumbnail

Researchers develop universal risk predictor for cardiovascular disease

Medical Xpress - Cardiology

Researchers from the Johns Hopkins Bloomberg School of Public Health have developed a single universal risk prediction model for cardiovascular disease that, in initial tests, works well for patients who already have cardiovascular disease as well as patients who do not but who may be at risk for developing it.

article thumbnail

Incentives Prompt Increased Daily Walking in Patients at Risk for Heart Disease

DAIC

Insights from behavioral economics can be applied in many other fields, including medicine and public health, Fanaroff said. We know that physical activity is important for cardiovascular health,” Fanaroff said. One technique, known as gamification, uses elements of game playing, such as competition and point scoring. “We

article thumbnail

Adverse Social Determinants of Health Linked to Treatment-resistant Hypertension in Black Americans

DAIC

Apparent treatment-resistant hypertension is defined as the need to take three or more types of anti-high blood pressure medication daily and is associated with an increased risk for stroke , coronary heart disease , heart failure , and all-cause mortality.

article thumbnail

Finally – the end (of the trial process)

Dr. Malcolm Kendrick

The case related to articles published in March 2019, containing allegations that Dr Harcombe and Dr Kendrick had made knowingly false statements about the cholesterol-lowering drug, statins; and that they had thereby caused large numbers of people not to take statins, causing harm to public health.

Article 105
article thumbnail

We have a judgment (Part 1)

Dr. Malcolm Kendrick

Because of our lies hundreds of thousands of people had stopped taking statins, resulting in (potentially) many thousands of heart attacks, strokes and deaths. In short, we were effectively accused of being liars, and ‘ purveyors of misinformation ’ about statins (drugs that lower LDL/cholesterol).

Article 109